Cimetidine, Urine
Cimetidine is a first generation H2 receptor antagonist antihistamine. Cimetidine is used to treat individuals that suffer from gastrointestinal disorders, such as heartburn or peptic ulcers. Cimetidine is a histamine antagonist. Histamine is synthesized in the body by the decarboxylation of the amino acid histidine.
Cimetidine is well absorbed after an oral dose and is 13% to 26% bound to protein. The duration of the physiological action is usually between 4-6 hours. Cimetidine is metabolized via the cytochrome 450 enzyme system.
Although antihistamines have a wide use in our society today and can be obtained without a prescription, cimetidine is not considered in the clinical laboratory as a drug of abuse. Therefore, there are no immunoassay kits available for detection. Generally, therapeutic concentrations of these drugs in the blood range from 0.5 to 5 mg/mL.
Cimetidine can be analyzed by a variety of analytical methods such as, Gas Chromatography/Mass spectroscopy (GC/MS), and Liquid Chromatography/Mass Spectroscopy (LC/MS).
- Therapeutic monitoring
- Postoperative analgesia
- Toxicity assessment
- Patient Compliance
General Therapeutic Level: 0.5 - 5 mg/mL
General Toxic level: >5 mg/mL
Note: therapeutic ranges and toxic thresholds are best evaluated from blood samples. Quantitative results obtained with blood samples collected at specific times after drug administration are preferred for pharmacokinetic analyses.
Cut-Off Ranges
Cut-off values can vary based on the particular method of analysis that is used for detection by a quantitative method, such as LC/MS or GC/MS. The testing laboratory cut-off range is listed on the patient report. Consult your physician for further information or click on one of the references that are listed below.
Urine:
Fresh urine specimen collected in either a clean glass or plastic container. An acceptable urine specimen submitted for testing should be in the pH range of 3-11. Adulteration of the urine specimen can result in erroneous results.
Stability
- Ambient: 5 days
- Refrigeration: 7 days
- Frozen: 30 days
Serum:
Serum specimens that are collected in a non-gel red top tube are the preferred specimens of choice. Specimens should be spun and the serum separated and refrigerated.
Stability
- Refrigeration: 7 days
- Frozen: 30 days
- Baselt RC (ed). Analytical procedures for therapeutic drug monitoring and emergency toxicology, 2nd ed. Littleton, MA: PSG Publishing Co.; 1987.
- Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 9th ed. Foster City, CA: Biomedical Publications; 2011.
- Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 6th ed. Forster City, CA: Biomedical Publications; 2002.
- Gupta RN. Review: drug level monitoring: sedative hypnotics. J Chromatography. 1985;340:139-72.
- Levine B (ed). Principles of Forensic Toxicology, 4th ed. Washington DC: AACC Press. Chapter 25, Antihistamines pp. 435-440; 2013.
- Brunton LL, Chabner B, Knollman B, eds. Goodman and Gilmans’ the pharmacological basis of therapeutics, 12th ed. New York: McGraw-Hill; 2010.
- Cooper FJ, Logan BK. Drugs and human performance fact sheets. Washington, DC: National Highway Traffic Safety Administration, U.S. Department of Transportation. DOT HS 809 725; 2004.
- Katzung BG, Masters S, Trevor AK (eds). Basic and clinical pharmacology, 12th ed. New York: McGraw-Hill; 2011.
- Stout PR, Farrell LJ. Opioids – Effects on human performance and behavior. Forensic Sci Rev. 2002;15:29-59.
- Wu A (ed). Tietz, clinical guide to laboratory test, 4th ed. Philadelphia: WB Saunders; 2006.